Aclaris Therapeutics (ACRS) Depreciation and Depletion (2014 - 2025)

Aclaris Therapeutics' Depreciation and Depletion history runs 12 years deep, the most recent figure standing at $100000.0 for Q3 2025.

• In Q3 2025, Depreciation and Depletion fell 50.0% year-over-year to $100000.0; the TTM figure through Sep 2025 stood at $400000.0 (down 50.0% YoY), while the FY2024 annual figure was $700000.0, down 12.5% from the prior year.
• Depreciation and Depletion was $100000.0 for Q3 2025 at Aclaris Therapeutics, roughly flat from $100000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $200000.0 in Q1 2021 to a low of $100000.0 in Q4 2022.
• Historically, Depreciation and Depletion has averaged $173684.2 across 5 years, with a median of $200000.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Depreciation and Depletion sank 50.0% in 2022, then surged 100.0% in 2023.
• A 5-year view of Depreciation and Depletion shows it stood at $200000.0 in 2021, then tumbled by 50.0% to $100000.0 in 2022, then soared by 100.0% to $200000.0 in 2023, then tumbled by 50.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
• The last three Depreciation and Depletion figures came in at $100000.0 (Q3 2025), $100000.0 (Q2 2025), and $100000.0 (Q1 2025), per Business Quant data.